Von Eschenbach’s Recusal Does Not Eliminate Conflicts, Democrats Say
This article was originally published in The Pink Sheet Daily
Executive Summary
In letter to Secretary Leavitt, three ranking house members denounce the acting commissioner’s promise of non-involvement in FDA decisions regarding the National Cancer Institute.